Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) Depreciation & Amortization - Total (2016)

Cross Country Healthcare (CCRN) has disclosed Depreciation & Amortization - Total for 7 consecutive years, with $1.1 million as the latest value for Q4 2016.

  • For the quarter ending Q4 2016, Depreciation & Amortization - Total rose 16.25% year-over-year to $1.1 million, compared with a TTM value of $1.1 million through Sep 2017, down 72.36%, and an annual FY2016 reading of $4.2 million, up 8.09% over the prior year.
  • Depreciation & Amortization - Total was $1.1 million for Q4 2016 at Cross Country Healthcare, up from $995000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $1.4 million in Q1 2012 and bottomed at $817000.0 in Q2 2014.
  • Average Depreciation & Amortization - Total over 5 years is $1.0 million, with a median of $1.0 million recorded in 2014.
  • The sharpest move saw Depreciation & Amortization - Total surged 43.39% in 2012, then fell 27.05% in 2013.
  • Year by year, Depreciation & Amortization - Total stood at $1.1 million in 2012, then dropped by 15.63% to $934000.0 in 2013, then increased by 14.56% to $1.1 million in 2014, then dropped by 10.84% to $954000.0 in 2015, then grew by 16.25% to $1.1 million in 2016.
  • Business Quant data shows Depreciation & Amortization - Total for CCRN at $1.1 million in Q4 2016, $995000.0 in Q3 2016, and $1.1 million in Q2 2016.